SKLB610
目录号: A13465
VEGFR 抑制剂
SKLB610 是一种新型潜在的血管内皮生长因子受体酪氨酸激酶抑制剂,在体内抑制血管生成和肿瘤生长。
Discription | SKLB610 is a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo. |
---|
目录号 | A13465 |
---|---|
分子式 | C21H16F3N3O3 |
分子量 | 415.11 |
CAS号 | 1125780-41-7 |
SMILES | CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)C3=CC(=CC=C3)C(F)(F)F |
其他名称 | SKLB 610, SKLB-610 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 77 mg/mL (185.38 mM) | |
Water | Insoluble | ||
Ethanol | 25 mg/mL (60.19 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 24.09 mL | 120.45 mL | 240.9 mL |
0.5 mM | 4.82 mL | 24.09 mL | 48.18 mL |
1 mM | 2.41 mL | 12.05 mL | 24.09 mL |
5 mM | 0.48 mL | 2.41 mL | 4.82 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2